| Upcoming events on INCYTE CORPORATION |
|
| 02/09/21 | 01:00pm | | Jahr 2020 Ergebnisveröffentlichung |
| 02/09/21 | 02:00pm | | Jahr 2020 Präsentation des Ergebnisses |
| 05/04/21 | | Q1 2021 Ergebnisveröffentlichung (geplant) |
| 08/03/21 | | Erstes Halbjahr 2021 Ergebnisveröffentlichung (geplant) |
|
| Past events on INCYTE CORPORATION |
|
| 01/11/21 | 01:30pm | | JP Morgan Healthcare Conference |
| 12/07/20 | 04:00pm | | American Society of Hematology Meeting |
| 12/01/20 | 04:30pm | | Evercore ISI HealthCONx Conference |
| 11/11/20 | | Society of Immunotherapy of Cancer Meeting - Poster Number - 268# |
|
| Upcoming sector events for INCYTE CORPORATION |
|
|
| |
|
| Past sector events for INCYTE CORPORATION |
|
|
|
|
|
| Annual results | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 (e) |
Sales
M $ |
Released
Forecast
Spread | 754
735
2,5% | 1 106
1 106
0,00% | 1 536
1 520
1,1% | 1 882
1 844
2,1% | 2 159
2 157
0,10% |
2 532
|
Operating income
(EBITDA)
M $ |
Released
Forecast
Spread | 95,5
23,5
307% | 203
213
-4,4% | -192
-171
-12% | 184
178
3,2% | 457
480
-4,9% |
-267
|
Operating profit
(EBIT)
M $ |
Released
Forecast
Spread | 50,7
17,6
188% | 145
158
-8,0% | -244
-209
-17% | 129
105
23% | 402
409
-1,8% |
-302
|
Pre-Tax Profit
(EBT)
M $ |
Released
Forecast
Spread | 7,56
-33,5
123% | 107
124
-14% | -312
-266
-17% | 115
120
-3,9% | 487
452
7,7% |
-267
|
Net income
M $ |
Released
Forecast
Spread | 6,53
-33,8
119% | 104
122
-14% | -313
-269
-17% | 109
90,8
21% | 447
418
7,0% |
-334
|
EPS
$ |
Released
Forecast
Spread | 0,03
-0,19
116% | 0,54
0,62
-13% | -1,53
-1,31
-16% | 0,51
0,42
21% | 2,05
1,89
8,7% |
-1,52
| | Announcement Date | 02/11/2016 | 02/14/2017 | 02/15/2018 | 02/14/2019 | 02/13/2020 | |
|
|
|
| Quarterly results | 2018 Q2 | 2018 Q3 | 2018 Q4 | 2019 Q1 | 2019 Q2 | 2019 Q3 | 2019 Q4 | 2020 Q1 | 2020 Q2 | 2020 Q3 | 2020 Q4 (e) | 2021 Q1 (e) | 2021 Q2 (e) | 2021 Q3 (e) | 2021 Q4 (e) |
Sales
M $ |
Released
Forecast
Spread | 522
511
2,1% | 450
448
0,48% | 528
486
8,8% | 498
486
2,4% | 530
499
6,3% | 552
534
3,2% | 579
575
0,78% | 569
553
2,8% | 688
614
12% | 621
622
-0,30% |
657
|
646
|
686
|
726
|
776
|
Operating income
(EBITDA)
M $ |
Released
Forecast
Spread | 96,7
92,9
4,2% | 44,9
37,0
21% | 96,2
123
-22% |
| 112
96,0
17% | 148
106
40% | 108
110
-1,7% |
| 243
211
15% | 18,3
129
-86% |
138
|
|
|
|
|
Operating profit
(EBIT)
M $ |
Released
Forecast
Spread | 83,2
71,9
16% | 31,1
30,6
1,8% | 82,0
62,0
32% | 74,1
59,2
25% | 98,6
57,9
70% | 134
86,5
55% | 95,0
96,2
-1,2% | -664
-652
-1,8% | 231
133
73% | 5,33
117
-95% |
132
|
94,2
|
172
|
205
|
119
|
Pre-Tax Profit
(EBT)
M $ |
Released
Forecast
Spread | 54,0
50,3
7,5% | 31,0
31,0
0,03% | 70,7
54,2
30% | 104
64,6
61% | 109
71,2
53% | 148
89,3
66% | 126
95,9
31% | -704
-690
-2,0% | 307
136
126% | -3,51
129
-103% |
142
|
101
|
107
|
117
|
125
|
Net income
M $ |
Released
Forecast
Spread | 52,4
47,7
9,9% | 29,2
32,8
-11% | 69,1
61,1
13% | 102
62,1
65% | 105
65,9
60% | 128
87,6
46% | 111
87,0
28% | -721
-666
-8,3% | 290
161
80% | -15,2
109
-114% |
120
|
72,7
|
91,9
|
103
|
116
|
EPS
$ |
Released
Forecast
Spread | 0,24
0,24
-1,2% | 0,14
0,15
-6,6% | 0,32
0,28
16% | 0,47
0,27
76% | 0,48
0,29
66% | 0,59
0,39
51% | 0,51
0,35
48% | -3,33
-3,09
-7,9% | 1,32
0,66
100% | -0,07
0,50
-114% |
0,50
|
0,42
|
0,51
|
0,59
|
0,67
| | Announcement Date | 07/31/2018 | 10/30/2018 | 02/14/2019 | 04/30/2019 | 07/30/2019 | 10/29/2019 | 02/13/2020 | 05/05/2020 | 08/04/2020 | 11/05/2020 | | | | | |
|
Financial data source
© 2021 S&P Global Market Intelligence
|
|
© 2021 Factset
|
|
|
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise
|
Canada
Deutschland
España
France
Italia
Schweiz (DE)
United Kingdom
Report
Previous period
